BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//hacksw/handcal//NONSGML v1.0//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
ORGANIZER;CN=Kymera Therapeutics, Inc.:MAILTO:no-reply@gcs-web.com
DTEND:
UID:c451b5ff-0957-42fd-8340-3c13bd0340a3
DTSTAMP:1795298306
LOCATION:https://kymera-event-y8329h2nfw.open-exchange.net/registration
DESCRIPTION:Event Details https://investors.kymeratx.com/events/event-details/kymera-therapeutics-kt-621-broaden2-phase-2b-atopic-dermatitis-trial-results\n\nWebcast: https://kymera-event-y8329h2nfw.open-exchange.net/registration
URL;VALUE=URI:https://kymera-event-y8329h2nfw.open-exchange.net/registration
SUMMARY:Kymera Therapeutics, Inc. - Kymera Therapeutics KT-621 BROADEN2 Phase 2b Atopic Dermatitis Trial Results
DTSTART:20261123T130000Z
END:VEVENT
END:VCALENDAR